Global biotech company with offices in South Africa hit by cyberattack

• Amgen, a global biotech company with offices in South Africa, has been hit by a cyberattack that resulted in the theft of patient information and proprietary data.
• The cyberattack was detected in July and involved unauthorized access to data stored in third-party cloud servers, with some data being exfiltrated from the cloud environment.
• The incident is under investigation, and while Amgen believes it will not have a material impact on financial results, it is the latest in a series of setbacks for the company, including safety questions over its drug Tavneos and declining sales of older medicines.